Latest news

eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health

AI transforming biotechnology: From form with AlphaFold to function with exozymes

Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper.

GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymes

GEN Biotechnology

GEN Biotechnology: Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space (cover story)

Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman

BioClick - an enzyme engineering game-changer

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer

Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes Provides Fourth Quarter and Full Year 2024 Update